Answers are grounded in this paper and cite their sources.
Neuronal apoptosis following spinal cord injury (SCI) critically contributes to neurological deficits. This study integrates bioinformatics and experimental validation to explore therapeutic targets and elucidate the protective role of CTNNB1 (encoding β-catenin) in SCI. Differential expression analysis and WGCNA were performed on GEO datasets to identify hub genes. In vitro oxygen-glucose deprivation (OGD) models and in vivo rat Allen’s impact models were established. CTNNB1-overexpressing HT22 cells were generated using lentivirus, with Wnt/β-catenin agonist (WCA3) and inhibitor (CCT036477) for rescue experiments. Apoptosis and pathway activity were assessed via Western blot, CCK-8, flow cytometry, and immunofluorescence. SCI rats received intraperitoneal injection of agonist, and functional recovery was evaluated by BBB scoring, footprint analysis, HE, and TUNEL staining. CTNNB1 was identified as a significantly downregulated hub gene post-SCI. Both in vivo and in vitro experiments confirmed that CTNNB1/β-catenin expression decreased as early as 6 h after injury. CTNNB1 overexpression in OGD models increased cell viability, reduced Cleaved Caspase-3 and Bax, and elevated Bcl-2 levels, effects reversible by Wnt/β-catenin inhibition. In vivo, agonist-mediated pathway activation improved motor function recovery, reduced spinal cord cavitation, and attenuated neuronal apoptosis. CTNNB1 exerts neuroprotection against neuronal apoptosis after SCI by activating the Wnt/β-catenin signaling pathway. The CTNNB1/Wnt/β-catenin axis represents a promising therapeutic target for SCI repair.
No takes yet. Share an insight, caveat, or question.
Qin et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: